Your Article Summary
See Latest ArticlesEtiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients
Cancer, 07/02/09
Granger JM et al. - Infection was an uncommon cause of extreme leukocytosis in patients with solid tumors. Patients with paraneoplastic leukemoid reactions typically were clinically stable despite having large tumor burdens. However, clinical outcomes were poor unless effective antineoplastic treatment was received.
Related Articles
Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin for chemotherapy-naive patients with extensive-disease small cell lung cancer
Cancer, 11/18/09
Relevance Score: 64%
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: CCTGcctg and SWOG study N0426
Journal of Clinical Oncology, 10/26/09
Relevance Score: 64%
A phase II study of intra-arterial chemotherapy of 5-fluorouracil, cisplatin, and mitomycin C for advanced nonresectable gastric cancer
Anti-Cancer Drugs, 10/15/09
Relevance Score: 64%
Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma
Cancer, 11/11/09
Relevance Score: 62%
Screening for Cancer
MedLinePlus, 11/02/09
Relevance Score: 49%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Two founder BRCA2 mutations predispose to breast cancer in young women
Breast Cancer Research and Treatment, 12/07/09
SULT1A1 R213H polymorphism and breast cancer risk: A meta-analysis based on 8,454 cases and 11,800 controls
Breast Cancer Research and Treatment, 12/07/09